Oncology Stock Spikes 24% Amidst Investment Firm's New Price Target

Cardiff Oncology Inc. Skyrockets, Piper Sandler Sets $7 Price Target.

Disclaimer: This article should not be construed as financial advice. Always conduct thorough research before investing in any stocks.

In a significant development that has caught the attention of investors, Cardiff Oncology Inc. (NASDAQ: CRDF) saw an impressive 24% surge in their stock price yesterday, closing at $3.58. This sudden upswing comes amidst …